Alexion Pharmaceuticals, Inc. · 3 weeks ago
Computational Biology Intern, PhD Students
Alexion Pharmaceuticals, Inc. is seeking doctoral level students for a 10-week internship in Computational Biology. The role involves designing a multi-agent AI system, validating biological domain knowledge, and integrating pipelines for proof-of-concept demonstrations.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Design and Build the Agentic Framework: Lead the design, rapid prototyping, and testing of a multi-agent AI system using Python and modern LLM/agentic frameworks (e.g., LangChain, AutoGen, Google ADK or similar)
Infuse and Validate Biological Domain Knowledge: Act as the "subject matter expert" to guide the AI. You will apply your deep knowledge of oncology/immunology to curate training data, design prompts for hypothesis generation, and critically evaluate the AI's outputs
Integrate and Demonstrate Pipelines: Integrate the separate agents into a single, end-to-end proof-of-concept pipeline constructing
Qualification
Required
Doctoral level students majoring in Computational Biology, Bioinformatics, Systems Biology, Biomedical Informatics (with a specialization in AI, ML, or genomics) or a related discipline. Candidates must have an expected graduation date after August 2026
High-Dimensional Genomics Data Handling: Proven experience in cleaning, preprocessing, and analyzing large biological datasets, such as RNA-seq, scRNA-seq, proteomics, or genomic data, is required
Coding Proficiency: Coding skills in R and Python, including libraries for scientific computing (NumPy, Pandas), are required
Agentic Frameworks & LLMs: Direct, hands-on experience with orchestration frameworks like LangChain, AutoGen, CrewAI, or similar tools used for building multi-agent systems and leveraging Large Language Models (LLMs) is required
Ability to report onsite to Waltham, MA 3-5 days per week. This role will not provide relocation assistance
US Work Authorization is required at time of application
This role will not be providing OPT support
Preferred
Oncology/Immunology: Specific experience or coursework focused on molecular pathways, disease mechanisms, and the interpretation of gene expression data are a plus
Deep Learning/ML Expertise: Experience with deep learning frameworks like PyTorch or TensorFlow is a plus
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase